...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Semi-synthesis and anti-tumor activity of 5,8-O-dimethyl acylshikonin derivatives.
【24h】

Semi-synthesis and anti-tumor activity of 5,8-O-dimethyl acylshikonin derivatives.

机译:5,8-O-二甲基酰基紫草素衍生物的半合成和抗肿瘤活性。

获取原文
获取原文并翻译 | 示例
           

摘要

A set of twenty-two 5,8-O-dimethyl acylshikonin derivatives were designed and synthesized starting from shikonin. The cell-based investigation demonstrated that these dimethylated derivatives were less active than or equally effective to shikonin. However, the selective cytotoxicities toward MCF-7 were found among these derivatives, together with no toxicity in the normal cell. Furthermore, compounds 3f, 3p, 3r were subjected to KM mice suffering from S-180 carcinoma subcutaneously, which possessed more potent than Fluorouracil, a typical anticancer drug used clinically. So we may conclude that the modification to the mother nucleus of shikonin via the methylation is an available approach to acquiring anti-tumor agents with higher selectivity and lower toxicity.
机译:从紫草素开始设计并合成了一组二十二种5,8-O-二甲基酰基紫草素衍生物。基于细胞的研究表明,这些二甲基化衍生物的活性低于或等同于紫草素。然而,在这些衍生物中发现了对MCF-7的选择性细胞毒性,并且在正常细胞中没有毒性。此外,将化合物3f,3p,3r皮下注射到患有S-180癌的KM小鼠中,该小鼠的功效比临床上使用的典型抗癌药物氟尿嘧啶要强。因此我们可以得出结论,通过甲基化修饰紫草素的母核是获得具有更高选择性和更低毒性的抗肿瘤药物的一种可行方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号